Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01094691 · ClinicalTrials.gov registry record · NA
Haufen Diagnostic Biomarkers of BK Renal Disease
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT01094691 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 50 participants.
The verdict
NCT01094691, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
To prospectively test whether the detection of three-dimensional, cast-like polyomavirus aggregates, termed Haufen, in voided urine samples can serve as an accurate biomarker of intra-renal disease, i.e. polyoma-BK-virus nephropathy (PVN). We want to correlate the detection of 'Haufen' with histologic findings made in renal biopsies as well as signs of polyomavirus activation, i.e. viremia and viruria. The prospective study is designed to further validate our retrospective findings (manuscript in press, J Am Soc Nephrology) and more specifically to correlate 'Haufen' shedding with the histologically confirmed course of PVN.
Interventions
- PROCEDURE Renal Allograft Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-11 |
| Est. Completion | 2019-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01094691
The ClinicalTrials.gov registry entry for NCT01094691 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renal Allograft Biopsy is the first listed.
NCT01094691 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01094691 about?
NCT01094691 is a clinical study titled "Haufen Diagnostic Biomarkers of BK Renal Disease". To prospectively test whether the detection of three-dimensional, cast-like polyomavirus aggregates, termed Haufen, in voided urine samples can serve as an accurate biomarker of intra-renal disease, i.e. polyoma-BK-virus nephropathy (PVN). We want to correlate the detection of 'Haufen' with histolog...
What is the current status of trial NCT01094691?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-11. Estimated completion is 2019-07.
What interventions are being tested in trial NCT01094691?
The interventions under investigation include: Renal Allograft Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT01094691?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.